InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by SAHA SAURABH, Chairman & CEO. Insider active across 2 companies, notably Centessa Pharmaceuticals plc. Aggregated, 6 filings have been logged. Total volume traded: €583k. The latest transaction was disclosed on 13 May 2026 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
€17,0328,178 shares@ €2.08260.0011% mcap100.0% of flow
Ordinary Shares
SEC:0001764046-26-000069·
€17,0328,178 shares@ €2.08260.0011% mcap50.0% of flow
Ordinary Shares
SEC:0001764046-26-000069:0·
€43,1975,000 shares@ €8.63940.0007% mcap14.8% of flow
Ordinary Shares
SEC:0000899243-22-004782·
Ideal exit: 30 Oct 2022 (T+270)
€43,1975,000 shares@ €8.63940.0007% mcap7.4% of flow
Ordinary Shares
SEC:0000899243-22-004782:0·
Ideal exit: 30 Oct 2022 (T+270)
€248,51323,000 shares@ €10.80490.0041% mcap85.2% of flow
Ordinary Shares
SEC:0000899243-21-045311·
Ideal exit: 13 Aug 2022 (T+270)
€248,51323,000 shares@ €10.80490.0041% mcap42.6% of flow
Ordinary Shares
SEC:0000899243-21-045311:0·
Ideal exit: 13 Aug 2022 (T+270)
6 of 6 declarations
About SAHA SAURABH
Saurabh Saha is the Chairman & CEO and Board Member of Centessa Pharmaceuticals plc and CLARIVATE PLC. In these roles, he oversees the operations and strategies of the companies, focusing on innovation and growth. His expertise in the pharmaceutical sector allows him to lead initiatives that enhance medical treatments and promote the development of new solutions.
